000 01332 a2200349 4500
005 20250514004809.0
264 0 _c20011025
008 200110s 0 0 eng d
022 _a0306-5251
024 7 _a10.1046/j.0306-5251.2001.01433.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aParameswaran, K
245 0 0 _aThe use of sputum cell counts to evaluate asthma medications.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cAug 2001
300 _a121-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenal Cortex Hormones
_xtherapeutic use
650 0 4 _aAdrenergic beta-Agonists
_xtherapeutic use
650 0 4 _aAnti-Asthmatic Agents
_xtherapeutic use
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aBronchodilator Agents
_xtherapeutic use
650 0 4 _aCell Count
650 0 4 _aDrug Monitoring
_xmethods
650 0 4 _aHumans
650 0 4 _aLeukotriene Antagonists
_xtherapeutic use
650 0 4 _aSputum
_xcytology
650 0 4 _aTheophylline
_xtherapeutic use
700 1 _aHargreave, F E
773 0 _tBritish journal of clinical pharmacology
_gvol. 52
_gno. 2
_gp. 121-8
856 4 0 _uhttps://doi.org/10.1046/j.0306-5251.2001.01433.x
_zAvailable from publisher's website
999 _c11415608
_d11415608